AbbVie jumped from No. 5 to No. 3 and AstraZeneca eked past GSK with a bump in profits. Here’s the top 10 list:
1. Johnson & Johnson: $93.8 billion
2. Pfizer: $81.3 billion
3. Roche: $62.8 billion
4. AbbVie: $56.2 billion
5. Novartis: $52.9 billion
6. Merck: $48.7 billion
7. Bristol-Myers Squibb: $46.4 billion
8. Sanofi: $39.2 billion
9. AstraZeneca: $37.4 billion
10. GSK: $34.1 billion
Note: These drug companies are ranked by total revenue and do not exclusively include pharmaceutical profits.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
